Endometriosis market to grow to $2.5 bn across 7MM in 2034
GlobalData’s latest report reveals that the strong growth of the endometriosis market will be primarily fueled by the introduction…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Endometriosis
NHS approval of endometriosis therapy Ryeqo enhances patient care: GlobalData
GlobalData’s report reveals that the endometriosis market size across the seven major markets is expected to achieve a compound…
Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US
Leuprolide acetate for depot suspension is a GnRH agonist used for the treatment of advanced prostatic cancer, endometriosis, and…
300 per cent increase in companies conducting endometriosis clinical trials since 2010: GlobalData
Bayer, Ferring International and AbbVie were among the most highly active sponsors with 21, 11 and seven trials, respectively
Oral GnRH antagonists have potential in female health beyond endometriosis pain and uterine fibroids
Oral GnRH antagonists could replace subcutaneous GnRH antagonists, which are commonly used in assisted reproductive technology…
FOGSI and Bayer launch care guidelines on endometriosis for doctors
VISION (Valuable Insights in Indian Endometriosis- Redefining Outcomes) will help address the challenges faced by physicians in…